| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +468.4% |
| Cost of Revenue | $1.2M | +554.3% |
| R&D Expense | $12.7M | +34.2% |
| SG&A Expense | $10.9M | +9.0% |
| Operating Income | -$23.3M | -20.3% |
| Pre-tax Income | -$22.8M | -18.6% |
| Net Income | -$22.8M | -18.6% |
| EPS (Basic) | -$0.57 | +8.1% |
| EPS (Diluted) | -$0.57 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -65.9% |
| Short-term Investments | $4.6M | -62.2% |
| Inventory | $67K | +0.0% |
| Current Assets | $9.5M | -60.2% |
| Total Assets | $13.0M | -48.9% |
| Current Liabilities | $2.1M | +50.0% |
| Total Liabilities | $2.4M | +72.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.5M | -19.5% |
| Capital Expenditures | $1.0M | +13.9% |
| Investing Cash Flow | $6.4M | +147.7% |
| Financing Cash Flow | $6.1M | -66.4% |
| Free Cash Flow | -$20.5M | -19.2% |
| +8.1% |
| Stockholders' Equity |
| $10.6M |
| -55.9% |